Looking for the mechanisms underlying hypofibrinolysis in AS, we demonstrated that α2-antiplasmin, the key plasmin inhibitor [29], is a crucial determinant of prolonged lysis time in patients with AS, regardless of the tPA concentration used. This evidence concerns the gene PLG and aortic stenosis.